Harmony Biosciences Holdings (HRMY) Non-Current Deffered Revenue (2019 - 2021)
Harmony Biosciences Holdings (HRMY) reported Non-Current Deffered Revenue of $192000.0 for Q1 2021, down 9.43% sequentially from $212000.0 in Q4 2020.
Harmony Biosciences Holdings (HRMY) Non-Current Deffered Revenue (2019 - 2021) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 3 years of Non-Current Deffered Revenue data on file, last reported at $192000.0 in Q1 2021.
- For the quarter ending Q1 2021, Non-Current Deffered Revenue changed N/A year-over-year to $192000.0; the trailing twelve-month figure through Mar 2021 stood at $192000.0 (changed N/A YoY), and the FY2020 full-year result was $212000.0, down 26.13% from the prior year.
- Non-Current Deffered Revenue declined to $192000.0 in Q1 2021, from $212000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $305000.0 in Q3 2020 to a low of $192000.0 in Q1 2021.
- A 3-year average of $249000.0 and a median of $249500.0 in 2019 frame the typical range for Non-Current Deffered Revenue.
- Peak annual rise in Non-Current Deffered Revenue reached 26.13% in 2020, while the deepest fall reached 26.13% in 2020.
- Tracing HRMY's Non-Current Deffered Revenue over 3 years: stood at $287000.0 in 2019, then slipped by 26.13% to $212000.0 in 2020, then fell by 9.43% to $192000.0 in 2021.
- Business Quant data shows HRMY's Non-Current Deffered Revenue at $192000.0 in Q1 2021, $212000.0 in Q4 2020, and $305000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 192,000.00 |
| Dec 31, 2020 | 212,000.00 |
| Sep 30, 2020 | 305,000.00 |
| Dec 31, 2019 | 287,000.00 |